A review of the amyloidoses that infiltrate the heart
- 1 August 1998
- journal article
- review article
- Published by Wiley in Clinical Cardiology
- Vol. 21 (8) , 547-552
- https://doi.org/10.1002/clc.4960210804
Abstract
Primary amyloidosis, systemic senile amyloidosis, isolated atrial amyloidosis, and transthyretin isoleucine 122 amyloidosis frequently involve the heart. Amyloid fibrils infiltrate the myocardium, impairing ventricular contraction and relaxation. The clinical manifestations of cardiac infiltration in these disorders are protean, though congestive heart failure and arrhythmias are most common. Treatment of cardiac amyloidosis is directed at the underlying cause and at relief of symptoms. Heart transplantation is not a viable treatment option for patients with primary amyloidosis; its role in the other amyloidoses has not been established. The prognosis of patients with cardiac amyloidosis varies and is largely determined by the underlying disorder responsible for amyloid infiltration.Keywords
This publication has 48 references indexed in Scilit:
- Revised transthyretin Ile 122 allele frequency in African-AmericansHuman Genetics, 1996
- DigitalisNew England Journal of Medicine, 1988
- Atrial natriuretic peptide deposited as atrial amyloid fibrilsBiochemical and Biophysical Research Communications, 1987
- Sensitivity and specificity of the echocardiographic features of cardiac amyloidosisThe American Journal of Cardiology, 1987
- Amyloid cardiomyopathy: Characterization by a distinctive voltage/mass relationThe American Journal of Cardiology, 1982
- Digoxin sensitivity in amyloid cardiomyopathy.Circulation, 1981
- M-mode and two-dimensional echocardiographic features in cardiac amyloidosis.Circulation, 1981
- Amyloid Deposits and AmyloidosisNew England Journal of Medicine, 1980
- Clinically significant cardiac amyloidosisThe American Journal of Cardiology, 1970
- The heart in primary systemic amyloidosisAmerican Heart Journal, 1946